Literature DB >> 8207402

Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis.

N Enomoto1, M Kurosaki, Y Tanaka, F Marumo, C Sato.   

Abstract

Hepatitis C virus (HCV) populations in vivo consist of heterogeneous mixtures of genetically different but closely related variants defined as a 'quasispecies'. The longitudinal fluctuation of HCV quasispecies populations in chronic hepatitis C has not been elucidated. Serial plasma samples were obtained from four patients with chronic hepatitis C (two patients without any treatment and two patients treated with interferon), and cDNA fragments containing the 5'-terminal region of the E2 gene of HCV were amplified from plasma RNA using PCR. Since conventional cloning of PCR products detects only a small part of the entire population, PCR products of each sample were separated by electrophoresis using single-strand conformation polymorphism (SSCP) analysis, which can distinguish DNA fragments of the same size as different electrophoretic bands depending on their sequence-specific conformation. Separated DNA fragments were recovered from SSCP bands in gels and their nucleotide sequences determined. SSCP electrophoresis separated PCR products into bands with different mobility. Sequence analysis of these bands confirmed that HCV populations in each patient are composed of quasispecies with different E2-hypervariable regions (HVR), which are known to contain antibody epitopes. Different patterns of variation in the HVR of quasispecies were observed in individual patients with different clinical features over time during chronic infection. Following interferon treatment, some quasispecies disappeared during the treatment and reappeared after the end of the treatment, whereas other quasispecies in the same patient remained during the treatment suggesting that the sensitivity to interferon is different among quasispecies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8207402     DOI: 10.1099/0022-1317-75-6-1361

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  23 in total

1.  Quasispecies as predictive response factors for antiviral treatment in patients with chronic hepatitis C.

Authors:  Javier Salmerón; Paloma Muñoz De Rueda; Angela Ruiz-Extremera; Jorge Casado; Carlos Huertas; Maria Del Carmen Bernal; Luis Rodríguez; Angel Palacios
Journal:  Dig Dis Sci       Date:  2006-05       Impact factor: 3.199

2.  Homogeneity of yellow fever virus strains isolated during an epidemic and a post-epidemic period in West Africa.

Authors:  M R Pisano; J Nicoli; H Tolou
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

3.  Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection.

Authors:  Xiping Zhao; Zhen-Ya Tang; Bettina Klumpp; Guido Wolff-Vorbeck; Heidi Barth; Shoshana Levy; Fritz von Weizsäcker; Hubert E Blum; Thomas F Baumert
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

Review 4.  Gene vaccination for hepatitis C.

Authors:  G Inchauspé
Journal:  Springer Semin Immunopathol       Date:  1997

5.  Duration of HCV infection as a predictor of nonresponse to interferon.

Authors:  A Craxì; V Di Marco; C Cammà; P Almasio; S Magrin
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

Review 6.  Hepatitis C virus: molecular biology and genetic variability.

Authors:  C Bréchot
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

7.  Selection of hepatitis C virus quasispecies during interferon treatment.

Authors:  I Sakuma; N Enomoto; M Kurosaki; F Marumo; C Sato
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

8.  Diversity of nucleotide sequences in hypervariable region 1 of hepatitis C virus in Japanese patients with chronic hepatitis C of unknown mode of transmission.

Authors:  H Toyoda; Y Fukuda; T Hayakawa; T Kumada; S Nakano; J Takamatsu; H Saito
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

9.  Mutations in the interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection.

Authors:  Mina Nakagawa; Naoya Sakamoto; Mayumi Ueyama; Kaoru Mogushi; Satoshi Nagaie; Yasuhiro Itsui; Seishin Azuma; Sei Kakinuma; Hiroshi Tanaka; Nobuyuki Enomoto; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2010-01-30       Impact factor: 7.527

10.  Molecular subtyping of human T-cell lymphotropic virus type 2 by single-strand conformation polymorphism analysis. Retrovirus Epidemiology Donor Study Group.

Authors:  W Heneine; W M Switzer; M Busch; R F Khabbaz; J E Kaplan
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.